Myst Therapeutics
AcquiredNovel tumor-infiltrating lymphocyte therapies for solid tumors
Los Angeles, United States · Founded 2019
- Headquarters
- Los Angeles, California
- Employees
- 1–10
- Founded
- 2019
- Website
- myst-tx.com
- Acquisition Date
- Jan 2021
About
Myst Therapeutics was a privately held biotechnology company focused on developing novel tumor-infiltrating lymphocyte (TIL) T-cell therapies for solid tumors. Founded in 2019 and headquartered in Los Angeles, California, the company built a proprietary TIL technology platform aimed at advancing next-generation cancer immunotherapy. Myst Therapeutics was acquired by Turnstone Biologics Corp. in January 2021, with its TIL technology and programs absorbed into Turnstone's broader cell therapy pipeline targeting solid tumors.
Summary
Myst Therapeutics is a Biotech company based in Los Angeles, United States, founded in 2019.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2021
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company